QPP Measure #410
Psoriasis: Clinical Response to Systemic Medications
Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient- reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatment.
Submission Methods: Registry
Measure Sets: Dermatology
Thank you for choosing Find-A-Code, please Sign In to remove ads.